Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06758726
What this trial is testing

Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT02461121
What this trial is testing

HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156
Not applicableLooking for participantsNCT01311258
What this trial is testing

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
University of Rochester 400
Early research (Phase 1)Ended earlyNCT00887926
What this trial is testing

Study of IMC-EB10 in Participant With Leukemia

Who this might be right for
Myeloid Leukemia
Eli Lilly and Company 25
Early research (Phase 1)Active Not RecruitingNCT05015426
What this trial is testing

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Ended earlyNCT01743807
What this trial is testing

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Who this might be right for
Relapsed Acute Lymphoblastic LeukemiaRelapsed Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 4
Early research (Phase 1)Study completedNCT00054236
What this trial is testing

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Case Comprehensive Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT01749111
What this trial is testing

Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disease+3 more
Hospital Israelita Albert Einstein 3
Not applicableNot Yet RecruitingNCT07269067
What this trial is testing

Automated vs Manual Flow-cytometry Gating for Measurable Residual Disease in Acute Myeloid Leukaemia (DUALFLOW)

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital, Bordeaux 60
Testing effectiveness (Phase 2)Study completedNCT03455504
What this trial is testing

Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 124
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableNot Yet RecruitingNCT07201233
What this trial is testing

Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression .

Who this might be right for
Bone Marrow Suppression
Shandong Qilu Stem Cells Engineering Co., Ltd. 30
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Early research (Phase 1)Study completedNCT00004932
What this trial is testing

STI571 in Treating Patients With Recurrent Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 31
Early research (Phase 1)Study completedNCT00020111
What this trial is testing

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00114764
What this trial is testing

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

Who this might be right for
Myeloid Leukemia
Amgen 84
Not applicableEnded earlyNCT03806192
What this trial is testing

Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Washington 12
Testing effectiveness (Phase 2)UnknownNCT05241106
What this trial is testing

HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tarapeutics Science Inc. 15
Early research (Phase 1)UnknownNCT01277484
What this trial is testing

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Seoul St. Mary's Hospital 19
Not applicableEnded earlyNCT04185428
What this trial is testing

Investigating Integrative Therapies for Symptom Management in Adults With Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Florida 9
Next Page